1. Ivanov D. O., Petrenko Yu. V., Shemyakina O. O., Fot A. Yu. Analiz antenatal'nykh faktorov riska formirovaniya vrozhdennykh porokov vnutrennikh organov u detej. Translyatsionnaya meditsina 2012, № 1, 61–68. [D. O. Ivanov, J. V. Petrenko, N. A. Treskina, E. S. Vagina, T. V. Mamaeva. Clinical case of congenital hyperinsulinism: diagnosis and treatment. Translational Medicine 2012, No.1, 61–68].
2. Ajrapetov D. Yu., Ordiyants I. M., Pobedinskaya O. S. Alloimmunnyj mekhanizm privychnogo nevynashivaniya beremennosti. Problemy reproduktsii 2010, T. 1, 86–88. [Airapetov D. Iu., Ordiiants I. M., Pobedinskaia O. S. Alloimmune factors in repeated fetal loss. Problemy reproduktsii 2010, Vol.1, 86–88].
3. Kiseleva A. N., Zajtseva G. A., Isaeva N. V., Butina E. V. Osobennosti polimorfizma genov sistemy HLA pri narusheniyakh protsessov reproduktsii. Mezhdunarodnyj nauchno-issledovatel'skij zhurnal 2015, T. 7, № 38, 23–24. [Kiseleva A. N., Zaitseva G. A., Isaeva N. V., Butina E. V. The peculiarities of hla-system genes polymorphism at reproductive process violation. International Research Journal 2015, Vol.7, no. 38, 23–24].
4. Saperova E. V., Vakhlova I. V. Vrozhdennye poroki serdtsa u detej: rasprostranennost', faktory riska, smertnost'. Voprosy sovremennoj pediatrii 2017, T. 16, № . 2, 126–133. [Saperova E. V., Vahlova I. V. Congenital Heart Diseases in Children: Incidence, Risk Factors, Mortality.Current pediatrics 2017, Vol. 16, no. 2, 126–133].
5. Tsepokina A. V., Shabaldin A. V., Litvinova N. A., Shmulevich S. A. Rol' polimorfnykh variantov HLADRB1* v razvitii vrozhdennykh porokov serdtsa. Sibirskij meditsinskij zhurnal 2016, № 2, 63–66. [Tsepokina A. V., Shabaldin A. V., Litvinova N. A., Shmulevich S. A. The role of polymorphic variants HLADRB1* in development of congenital heart diseases. Siberian Medical Journal 2016, 2016, no. 2, 63–66].